Wound closure technologies

ETHICON, a division of Johnson & Johnson Medical, is committed to working with healthcare professionals to reduce the risk of surgical site infection. A leader in wound closure, the company will be highlighting the latest technologies to help fight against infection.

Ethicon’s antibacterial suture, Coated Vicryl Plus Suture, is effective against the bacteria that cause the majority of SSIs, including MRSA. By preventing bacterial colonisation of the suture, Coated Vicryl Plus Suture provides protection for the patient where it is needed most – right at the site of the incision.

Dermabond Topical Skin Adhesive (2-Octyl Cyanoacrylate) eliminates the need for suture removal and dressings and has a microbial barrier that seals out bacteria that could lead to infection. It provides the strength of healed tissue at seven days in less than three minutes.

Latest Issues

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

IGPP Annual Operating Theatres Show

Manchester, Etihad Stadium
11th September 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025